Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found in variants of concern(1). As a result...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Alice, Muecksch, Frauke, Schaefer-Babajew, Dennis, Wang, Zijun, Finkin, Shlomo, Gaebler, Christian, Ramos, Victor, Cipolla, Melissa, Mendoza, Pilar, Agudelo, Marianna, Bednarski, Eva, DaSilva, Justin, Shimeliovich, Irina, Dizon, Juan, Daga, Mridushi, Millard, Katrina G., Turroja, Martina, Schmidt, Fabian, Zhang, Fengwen, Tanfous, Tarek Ben, Jankovic, Mila, Oliveria, Thiago Y., Gazumyan, Anna, Caskey, Marina, Bieniasz, Paul D., Hatziioannou, Theodora, Nussenzweig, Michel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674133/
https://www.ncbi.nlm.nih.gov/pubmed/34619745
http://dx.doi.org/10.1038/s41586-021-04060-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674133/
https://www.ncbi.nlm.nih.gov/pubmed/34619745
http://dx.doi.org/10.1038/s41586-021-04060-7

Ejemplares similares